GILD and REGN Related Headlines
Go Back- 4Q25/2026 Biotech Earnings Preview: RBC
- Trump to announce prescription drug price agreements
- RBC Capital on Biotech: 'Who Wins and Who Loses If RFK, Jr. Goes'
- Buy this U.S. large-cap biopharma stock: JPMorgan
- Trump demands pharma CEOs lower drug prices within 60 days
- Trump Posts Letters to Regeneron, Merck, AstraZeneca, GSK, Pfizer, Novo Nordisk, Amgen, Bristol-Myears, AbbVie, Novartis, Gilead, J&J on Truth Social
- Biotech stocks dip as Trump administration mulls patent fee overhaul
